Kimberly Dahlman

March 21, 2019

Cancer researcher Kimberly Dahlman is too busy to run in the Boston Marathon, but she’s doing it anyway — for her daughter

“Even though I felt like I was already over-committed, I knew that I needed to do this”

By Leigh MacMillan
October 29, 2015

Investigators find clues to melanoma treatment resistance

Nearly half of all patients with malignant melanoma, the most deadly form of skin cancer, have a mutation in the BRAF gene found in their tumors. Mutations in the BRAF gene turn on a cancer growth switch known as the MAP kinase pathway.

By VUMC News and Communications
September 25, 2014

Bradfords’ strong support bolsters melanoma research

When something attacks you, you want to attack it back. That’s how Lillian “Tooty” Bradford views her late husband James “Jimmy” Bradford Jr.’s decision to make an initial gift to fund melanoma research at Vanderbilt-Ingram Cancer Center (VICC).

By Christina Echegaray
January 26, 2012

Investigators seek clues to resistance to melanoma drug

Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug.

By VUMC News and Communications